MedTrace Logo

Effect of Nicotine on Chronic Pelvic Pain

NCT00440505 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-08-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test whether transdermal nicotine reduces pain among women with chronic pelvic pain.

Conditions

  • Pelvic Pain

Interventions

DRUG

Placebo

Subjects applied a placebo patch (0 mg) in the morning and removed it at bedtime for one day.

DRUG

Nicotine (5 mg)

Subjects applied a nicotine patch (5 mg) in the morning and removed it at bedtime for one day.

DRUG

Nicotine (10 mg)

Subjects applied a nicotine patch (10 mg) in the morning and removed it at bedtime for one day.

Sponsors & Collaborators

Principal Investigators

  • Pamela Flood, MD · Columbia University

  • Jessamyn Conell-Price, BA · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00440505 on ClinicalTrials.gov